Why Shares of Invivyd Jumped This Week
Yahoo! Finance
Shares of Invivyd (NASDAQ: IVVD) were up 35.4% for the week as of Thursday afternoon. The clinical-stage biopharmaceutical company specializes in using monoclonal antibodies to treat highly infectious viral respiratory diseases, such as SARS, caused by the SARS coronavirus, and influenza. Invivyd has a small market cap ($270 million) and a low share price, so it doesn't take much to move the needle.
Continue Reading